The U.S. Food and Drug Administration today approved the first generic versions of prescription Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). Such infections occur when fungi invade a fingernail or toenail or the skin underneath the nail.
A new effort to eliminate Chagas disease by 2010 will be launched tomorrow at a WHO meeting of disease experts and partners. The strategy is designed to answer key questions about the treatment and control of Chagas disease, and to coordinate global efforts towards the prevention of transmission through a new Global Network for Chagas Elimination.
A study appearing in the July issue of the Journal of Periodontology found bacteria commonly found in the mouth and associated with periodontal diseases in the amniotic fluid of some pregnant women.
It infiltrates hospitals as microscopic spores. Its defenses are so strong it can resist most antibiotics. And it kills three times as many people every year as MRSA. But scientists at the University of Nottingham are amassing an arsenal of weapons in preparation for counter offensive against the most deadly of hospital superbugs.
Variations in two genes related to inflammation may be a major risk factor for developing lung cancer, according to a team of scientists from the National Cancer Institute and the University of Texas M. D. Anderson Cancer Center.
In the July 2 issue of the Journal of Clinical Investigation, Adrian Martineau, Robert Wilkinson, and colleagues from the Wellcome Trust Center for Research in Clinical Tropical Medicine in London report that the activity of white blood cells known as neutrophils is one reason why some individuals exposed to the infectious bacterium Mycobacterium tuberculosis resist developing evidence of tuberculosis (TB) infection for longer than their peers.
An antibody frequently used as a diagnostic marker for multiple sclerosis (MS) is present at greater levels in the cerebrospinal fluid of blacks with MS than Caucasians with the disease.
A new study on predicting outcomes of standard treatment for hepatitis C virus (HCV) infection found that a number of factors impacted responses, including the form of the interferon given. However, for some genotypes of the disease, few of these factors play a role.
An international team of investigators has identified the first human antibodies that can neutralize different strains of virus responsible for outbreaks of severe acute respiratory syndrome (SARS). The researchers used a mouse model and in vitro assays (lab tests) to test the neutralizing activity of the antibodies.
People who have high cholesterol levels may be much more susceptible to a particular disease transmitted by the bites of ticks, a new study in mice suggests.